Gameto Raises $44M in Series C

Gameto has successfully raised $44M in a Series C at a $250M valuation led by Future Ventures, Khosla Ventures.

Company Overview

Gameto is a Biotech company headquartered in Austin, TX, founded in 2020 with 60+ employees.

Stem cell-derived therapies for reproductive health

Fundraising Details

• Amount Raised: $44M
• Round Type: Series C
• Valuation: $250M
• Date: 2025-09-27
• Investors: Future Ventures, Khosla Ventures

About Gameto

Stem cell-derived therapies for reproductive health The company is positioned in the Biotech sector, serving a growing market with innovative solutions.

Key Information

• Headquarters: Austin, TX
• Founded: 2020
• Team Size: 60+
• Industry: Biotech

What This Means

This funding round demonstrates strong investor confidence in Gameto's vision and execution. The capital will likely be used to:

• Scale Operations: Expand the team and operational capacity
• Product Development: Enhance existing products and develop new features
• Market Expansion: Enter new markets and strengthen presence in existing ones
• Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Gameto's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $250M valuation marks an important milestone for Gameto, positioning the company among notable players in the Biotech industry.

Looking Ahead

With this new capital, Gameto is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-09-27. For more information about Gameto, visit their headquarters at Austin, TX.